Business
Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of 5th Product License for MultiXThick Radiographic Barium Contrast
(TheNewswire) Calgary, Alberta - TheNewswire - May 17, 2021 - Voy...
About this update from Voyageur Pharmaceuticals Ltd
[{"type":"text","content":"Voyageur Pharmaceuticals Ltd. Announces Health Canada Approval and Issuance of 5th Product License for MultiXThick Radiographic Barium Contrast\n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n Calgary, Alberta -\n \n \n TheNewswire\n-\n \n \n May 17, 2021 -\n \n \n Voyageur Pharmaceuticals Ltd.\n \n \n (\n \n \n TSXV:VM)\n \n \n (\n \n \n OTC:VYYRF\n \n \n ) (the \"Company\" or\n\"Voyageur\") is pleased to announce that it has received\napproval from Health Canada (HC) for its fifth product,\n \n \n MultiXthick barium sulfate\nsuspension\n \n \n that contains 105% w/v barium sulfate\nsuspension for oral and rectal administration of the gastrointestinal\ntract.\n \n \n \n \n Voyageur has built a full suite of barium radiographic\ncontrast media products for global sales and  distribution. The\nfollowing products  have  been  licensed:\n \n \n \n \n \n \n - SmoothX –                 For CT\nmarket\n \n \n \n \n - HDX –                 For Flouroscopy\nmarket\n \n \n \n \n - LDX –                 For Fluoroscopy\nmarket\n \n \n \n \n - MultiXthin –         For Flouroscopy\nmarket\n \n \n \n \n - MultiXthick-         For Flouroscopy\nmarket\n \n \n \n \n \n \n Voyageur is focused on rolling out all its products in\na timely manner. Smoothies for CT scans is one of the  top volume\nselling products in  the USA and Canada. Voyageur is focused on\nlaunching SmoothX as our initial product to market. Voyageur is\ncurrently optimizing blending formulations and manufacturing\nprocedures to bring its newly-formulated products under GMP and HC\nguidelines. Voyageur will be working with a Canadian based imaging\nclinic to run clinical tests on patients to ensure our product meets\nand exceeds the requirements for computed Tomography before we enter\nthe market.  Voyageur plans to ensure that it is creating the highest\nquality products prior to phase one marketing, sales and distribution\nto Canadian, USA and international markets.\n \n \n \n \n FDA applications are in progress and our objective is\nto acquire FDA device licensing to coincide with  our product roll\nout.\n \n \n \n \n Voyageur has begun business and pro...